NCT03075657View on ClinicalTrials.gov

Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

June 15, 2018

Study Completion Date

August 31, 2018

Conditions
Schizophrenia
Interventions
DRUG

Risperidone

Risperidone will be prescribed at dose of 2 mg per day

DRUG

Risperidone and Ramelteon

Ramelteon will be prescribed 8mg/day as an add-on therapy to Risperidone 2 mg per day

DRUG

Haloperidol

Haloperidol will be prescribed at a dose of 4 mg per day

DRUG

Haloperidol and Ramelteon

Ramelteon will be prescribed 8mg/day as an add-on therapy to Haloperidol 4 mg per day

Trial Locations (1)

751019

All India Institute of Medical Sciences (AIIMS), Bhubaneswar

All Listed Sponsors
lead

All India Institute of Medical Sciences, Bhubaneswar

OTHER

NCT03075657 - Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter